Loading...
XSTO
2CUREX
Market cap588kUSD
Apr 11, Last price  
0.35SEK
1D
4.19%
1Q
-17.14%
IPO
-94.92%
Name

2cureX AB

Chart & Performance

D1W1MN
P/E
—
P/S
37.08
EPS
—
Div Yield, %
—
Shrs. gr., 5y
11.21%
Rev. gr., 5y
-54.18%
Revenues
155k
+72.22%
2,234,7101,347,05647,0007,675,00011,982,00015,391,0007,391,00090,000155,000
Net income
-33m
L+18.65%
00-3,136,000-7,264,000-7,933,000-7,320,000-18,937,000-27,407,000-32,518,000
CFO
-5m
L-85.18%
01,206,538-4,348,0001,150,000-7,864,000-11,694,000-18,426,000-27,984,000-31,222,000-4,626,000

Profile

2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
URL
https://www.2curex.com/
IPO date
Nov 24, 2017
Employees
14
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
155
72.22%
90
-98.78%
Cost of revenue
37,642
47,886
Unusual Expense (Income)
NOPBT
(37,487)
(47,796)
NOPBT Margin
Operating Taxes
(4,629)
(2,363)
Tax Rate
NOPAT
(32,858)
(45,433)
Net income
(32,518)
18.65%
(27,407)
44.73%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
51
1,629
Net debt
(5,140)
(13,403)
(44,894)
Cash flow
Cash from operating activities
(4,626)
(31,222)
(27,984)
CAPEX
(17)
(541)
Cash from investing activities
5,617
(17)
(541)
Cash from financing activities
2,690
FCF
703
(32,568)
(45,024)
Balance
Cash
5,140
13,403
44,894
Long term investments
Excess cash
5,140
13,395
44,890
Stockholders' equity
(1,618)
(30,758)
(28,010)
Invested Capital
6,717
42,887
70,908
ROIC
ROCE
EV
Common stock shares outstanding
17,603
17,581
Price
0.42
-79.00%
2.01
-75.34%
8.15
-51.49%
Market cap
35,382
-75.31%
143,285
-48.05%
EV
21,979
164,781
EBITDA
(37,175)
(47,485)
EV/EBITDA
Interest
1,617
2,363
Interest/NOPBT